How much funding has Innovative Biotherapies, Inc. raised?

Innovative Biotherapies, Inc. has raised $2.7M in total funding, most recently a Grant round.

Who are Innovative Biotherapies, Inc.'s investors?

Innovative Biotherapies, Inc.'s investors include National Institutes of Health.

When was Innovative Biotherapies, Inc. founded?

Innovative Biotherapies, Inc. was founded in 2015.

Where is Innovative Biotherapies, Inc. headquartered?

Innovative Biotherapies, Inc. is headquartered in Ann Arbor, Michigan, United States.

What industry is Innovative Biotherapies, Inc. in?

Innovative Biotherapies, Inc. operates in Biotech, Healthcare.

How many employees does Innovative Biotherapies, Inc. have?

Innovative Biotherapies, Inc. has 11-50 employees.

Innovative Biotherapies, Inc.

innbio

Ann Arbor, United States · Founded 2015 · $2.7M raised

Biotech

Healthcare

Headquarters: Ann Arbor, Michigan
Employees: 11–50
Founded: 2015
Business Model: B2B

Website: innbio.com
Total Funding: $2.7M
Last Round: $2.7M GrantMay 2024
Rounds: 1

About

Innovative BioTherapies (IBT) develops bioartificial organ-based medical devices using adult progenitor cells, biomaterials, and MEMs technology. Its lead product, the Selective Cytopheretic Device (SCD), targets inflammatory conditions including Acute Kidney Injury, ARDS, and Multiple Organ Dysfunction. Founded in 2003 by Dr. H. David Humes, a University of Michigan professor of medicine.

Summary

Innovative Biotherapies, Inc. is a Biotech company based in Ann Arbor, United States, founded in 2015. It has raised $2.7M in total across 1 round, most recently a $2.7M Grant round in May 2024. Investors include National Institutes of Health.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

GrantMay 2024

$2.7M

May 2024

Investors

National Institutes of Health

Lead

1 round

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare

Growth Equity·$5.1B·Aug 2022

IVI-RMA

IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...

Valencia, Spain5001–10000Biotech, Healthcare

Private Equity·$3.3B·Apr 2022

Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech

Series A·$3.0B·Jan 2022

inVentiv HealthAcquired

inVentiv Health merged with INC Research to form Syneos Health, integrating clinical and commerci...

Burlington, United States5001–10000Biotech, Healthcare

Private Equity·$3.0B·May 2017

Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare

Private Equity·$3.0B·Jan 2004

BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology

Corporate Round·$2.8B·Jan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Innovative Biotherapies, Inc. on Indexed.vc

<a href="https://indexed.vc/companies/innovative-biotherapies-inc"><img src="https://indexed.vc/api/badge/company/innovative-biotherapies-inc" alt="Innovative Biotherapies, Inc. on Indexed.vc" width="260" height="76" /></a>